|
|
||||||||
American Journal of Clinical Nutrition, Vol 48, 72-83, Copyright © 1988 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
G Deferrari, G Garibotto, C Robaudo, M Sala and A Tizianello
Istituto Scientifico di Medicina Interna, University of Genoa, Italy.
Splanchnic exchange (net uptake or release) of amino acids (AAs) was evaluated by measuring arterial-hepatic venous differences for AAs and hepatic blood flow in patients with chronic renal insufficiency (CRI) and control subjects before and for 70 min after the ingestion of an AA mixture simulating an animal protein meal. In CRI after AA ingestion, splanchnic exchange area for total nonessential AAs (NEAAs) is increased 135% over control subjects because of an augmented escape of proline, glutamate, serine, glycine, alanine, and cyst(e)ine; contrarily, glutamine shows an increased splanchnic uptake. Splanchnic exchange area for total essential AAs (EAAs) is increased only by 67% over controls because of a higher escape of threonine, isoleucine, phenylalanine, and histidine. Abnormalities in arterial areas for AAs parallel those in splanchnic areas except for glutamine and isoleucine. Data indicate that in CRI, at least for 70 min after an AA meal, splanchnic organs metabolize abnormally ingested AAs and export an increased and unbalanced bulk of AAs, severely affecting postprandial arterial profile of AAs.
This article has been cited by other articles:
![]() |
J. J. Carrero, A. Witasp, P. Stenvinkel, A. R. Qureshi, O. Heimburger, P. Barany, M. E. Suliman, B. Anderstam, B. Lindholm, L. Nordfors, et al. Visfatin is increased in chronic kidney disease patients with poor appetite and correlates negatively with fasting serum amino acids and triglyceride levels Nephrol. Dial. Transplant., March 1, 2010; 25(3): 901 - 906. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-E. Heng and N. J. M. Cano Nutritional problems in adult patients with stage 5 chronic kidney disease on dialysis (both haemodialysis and peritoneal dialysis) NDT Plus, October 19, 2009; (2009) sfp147v1. [Full Text] [PDF] |
||||
![]() |
J. D. Kopple Phenylalanine and Tyrosine Metabolism in Chronic Kidney Failure J. Nutr., June 1, 2007; 137(6): 1586S - 1590S. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. M. Cano, D. Fouque, and X. M. Leverve Application of Branched-Chain Amino Acids in Human Pathological States: Renal Failure J. Nutr., January 1, 2006; 136(1): 299S - 307S. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Ziegler, K. Benfell, R. J. Smith, L. S. Young, E. Brown, E. Ferrari-Baliviera, D. K. Lowe, and D. W. Wilmore Safety and Metabolic Effects of L-Glutamine Administration in Humans JPEN J Parenter Enteral Nutr, July 1, 1990; 14(4_suppl): 137S - 146S. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |